Latest approved medicines worldwide at your doorstep, legally...
|
|
|
- Gillian Turner
- 5 years ago
- Views:
Transcription
1 Latest approved medicines worldwide at your doorstep, legally... Exporters of healthcare products
2 Nostrum Impex is engaged in exports of approved pharmaceutical medicines and offer a wide range of products in hepatitis, oncology, nephrology, critical care treatments. We ventured into export business of healthcare products in the global market in We offer support in import of research drugs and other original drug formulations including patient name imports. During the past financial year, have successfully delivered over orders worldwide. We are admired in the market for fast and quality service. We have our presence in Russia, China, Australia and countries in Southeast Asia. With clients in over 30 countries and we have been associated with clinicians for the treatment of hepatitis, oncology, nephrology and critical care patients worldwide. As part of expansion, we are looking forward to business opportunities in the healthcare field in Africa, USA and European countries.
3 Hepatitis We offer a wide range of products used in the treatment of Hepatitis, mainly Hepatitis C. We provide originator brands as well as licensed generics to make it affordable to our clients.
4 We cater the best of products available for cancer therapy, nephrology and critical care to our clients, at unmatched rates. Cancer therapy Nephrology Critical care
5 A glance from our catalogue of over products Item Name Marketed by Discription Abirapro 250mg 120s Glenmark Abiraterone Acetate 250mg Abstet 120s Biocon Abiraterone Acetate 250mg Xbira 120s Cipla Abiraterone Acetate 250mg Zecyte 120s Cipla Abiraterone Acetate 250mg Zelgor 120s Sun Pharma Abiraterone Acetate 250mg Mucomix 1gm 5s x 5 Samarth Life Sciences Pvt Ltd Actylcysteine Injection BP 1mg 5ml 25s Xovoltib 40mg 30s Boehringer Ingelheim Afatinib 40mg Aprecap Set 1s Glenmark Aprepitant Capsules Waklert 150mg 10s Sun Armodafinil 150mg Bendit 100mg 1s Natco Bendamustine HCL 100mg Urotone 25mg 10s x 5 Samarth Life Sciences Pvt Ltd Bethanechol Chloride Tablets Usp Lumigan 0.03% 1s Allergan Bimatoprost 0.3mg/ml 3ml 1s Bortenat 2mg 1s Natco Bortezomib 2mg Bipivac 50mg 1s Aesmira Bupivacaine Injectionip Xeloda 500mg 10s x 12 Roche Capecitabine 500mg Capnat 500mg 10s x 10 Natco Capecitabine Tablets IP 500mg Kyprolis 60mg 1s Amgen Carfilzomib 60mg Spexib 150mg 150s GSK Ceritinib 150mg PTH 30mg 10s Intas Cinacalcet 30mg Plavix 75mg 14s Sanofi Winthrop Industrie Clopidogrel 10 Tablets14s I.P Crizalk 250mg 10s x 6 Pfizer Crizotinib 250mg Dacihep 28s Zydus Daclatasvir 60mg Daclafab 28s Sun Pharma Daclatasvir 60mg Daclahep 28s Hetero Daclatasvir 60mg Daclawin 28s Biocon Daclatasvir 60mg Daclitof 28s Wockhardt Daclatasvir 60mg Dactovin 28s Strides Daclatasvir 60mg Dalsiclear 28s Abbott Daclatasvir 60mg Hepcifix 28s DrReddys Daclatasvir 60mg Mydacla 28s Mylan Daclatasvir 60mg Natdac 28s Natco Daclatasvir 60mg Daruvir 600mg 60s Cipla Darunavir 600mg Desferal 500mg 1s Novartis Deferoxamine Mesylate 500mg Instgra 50mg 30s Emcure Dolutegravir 50mg 30s Efavir 30s Cipla Efavirenz IP 600mg Trustiva 30s Genx Hetero Efavirenz IP 600mg + Emtricitabine IP 200mg + Tenofovir Disoproxil Fumarate IP 300mg Viraday 30s Cipla Efavirenz IP 600mg + Emtricitabine IP 200mg + Tenofovir Disoproxil Fumarate IP 300mg Revolade 25mg & 50mg Novartis Eltrombopag 25mg Tenvir EM 30s Cipla Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg Entavir 0.5mg, 1mg 10s Cipla Entecavir 0.5mg Entehep 0.5mg, 1mg 10s Zydus Entecavir 0.5mg X-Vir 0.5mg 30s Natco Entecavir 0.5mg Xtandi 40mg 112s Astellas Enzalutamide 40mg Erlonat 30s Natco Erlotinib 150mg Esocard 100mg 1s Samarth Life Sciences Pvt Ltd Esmolol Hydrochloride Injection 100mg 100ml Afinitor 5mg, 10mg Novartis Everolimus Evertor 5mg & 10mg Biocon Everolimus Evermil 10mg 10s Glenmark Everolimus
6 Item Name Marketed by Discription Zurig 80mg 30s Cadila Febuxostat Tablets 30s Finpecia 1mg 15s x 10 Cipla Finasteride Tablets IP1 mg Anexate 0.5mg 5s Roche Flumazenil 0.5mg Flomist 10ml 1s Cipla Fluticasone & Benzalkonium 10ML Natclovir 250mg 10s x10 Natco Ganciclovir 250mg Geftinat 30s Natco Gefitinib 250mg Zoladex 3.6mg 1s AstraZeneca PLC Ingiltere Goserelin 3.6mg Imbruvica 140mg 90s Janssen Ibrutinib 140mg Veenat 100mg & 400mg Natco Imatinib 100mg Duovir 60s Cipla Lamivudine IP 150mg + Zidovudine IP 300mg Duovir N 30s Cipla Lamivudine IP 150mg + Zidovudine IP 300mg + Nevirapine IP 200mg Fosbait 500mg 30s Panacea Lanthanum Carbonate 500 mg Tykerb 250mg Novartis Lapatinib 250mg Cimivir L 28s Biocon Ledipasvir 90mg + Sofosbuvir 400mg Harvoni 28s Gilead Ledipasvir 90mg + Sofosbuvir 400mg Hepcinat LP 28s Natco Ledipasvir 90mg + Sofosbuvir 400mg Hepcivir L 28s Cipla Ledipasvir 90mg + Sofosbuvir 400mg Ledifos 28s Hetero Ledipasvir 90mg + Sofosbuvir 400mg Ledihep 28s Zydus Ledipasvir 90mg + Sofosbuvir 400mg Ledviclear 28s Abbott Ledipasvir 90mg + Sofosbuvir 400mg MyHep Lvir 28s Mylan Ledipasvir 90mg + Sofosbuvir 400mg Novisof L 28s Wockhardt Ledipasvir 90mg + Sofosbuvir 400mg Reclaim L 28s Lupin Ledipasvir 90mg + Sofosbuvir 400mg Resof L 28s DrReddys Ledipasvir 90mg + Sofosbuvir 400mg Sofab LP 28s Sun Pharma Ledipasvir 90mg + Sofosbuvir 400mg Twinvir Incepta Ledipasvir 90mg + Sofosbuvir 400mg Virpas 28s Strides Ledipasvir 90mg + Sofosbuvir 400mg Lenalid 10mg 30s Natco Lenalidomide 10mg Lenalid 25mg 30s Natco Lenalidomide 25mg Femara 2.5mg 30s Novartis Letrozole 2.5mg Aluvia 120s Abbott Lopinavir IP 200mg + Ritonavir IP 50mg Lipomune 60s Cipla Lopinavir IP 200mg + Ritonavir IP 50mg Erwinase 10k 5s Jazz Pharmaceuticals Lyophilisate for solution for injection Alphalan 2mg 25s Natco Melphalan 2mg Cellcept 500mg 10s x 5 Roche Mycophenolate Mofetil 500mg Nitrocin 50mg 1s x 5 Samarth Life Sciences Pvt Ltd Nitroglycerin Injection USP Opdivo 100mg 1s Birstol-Myers Squibb Nivolumab 100mg Xolair 150mg 1s Novartis Omalizumab 150mg Qurevo 28s Abbvie Ombitasvir 12.5mg + Paritaprevir 75mg + Ritonavir 50mg Tagrix 80mg 10s x 3 Beacon Osimertinib 80mg Osicent 80mg 30s Incepta Osimertinib 80mg 30s Palbace 125mg 21s Pfizer Palbociclib 125mg Noxafil 105ml 1s MSD Pasaconazole Oral Suspension Votrient 200mg & 400mg GSK Pazopanib Hydrochloride 200mg Keytruda 100mg 1s MSD Pembrolizumab Pemmet 500mg 1s Intas Pemetrexed 500mg Cuprenil 250mg 100s Teva Penicillamine 250mg Pirfenex 10s x 3 Cipla Pirfenidone 200mg Quetigress 25mg 10s x 10 LaRenon Quetiapine 25mg Isentress 400mg 60s MSD Raltegravir 400mg Zepdon 60s Cipla Raltegravir 400mg
7 Item Name Marketed by Discription Nublexa 40mg 28s Bayer Regorafenib 40mg Resihance 40mg 28s Bayer Regorafenib 40mg Rilutek 50mg 56s Sanofi Aventis Riluzole 50mg Ritomune 60s Cipla Ritonavir IP 100mg Jakavi 5mg, 15mg & 20mg Novartis Ruxolitinib 15mg Heptral 10s Abbott S-Adenosyl methionine 400mg Scapho 150mg 1s Novartis Secukinumab 150mg Suhagra 100mg 4s Cipla Sildenafil Citrate 100mg Viagra 100mg 1s Pfizer Sildenafil Citrate 100mg Olysio 150mg 7s x 4 Janssen Simeprevir 150mg Cimivir 28s Biocon Sofosbuvir 400mg Hepcinat 28s Natco Sofosbuvir 400mg Hepcivir 28s Cipla Sofosbuvir 400mg MyHep 28s Mylan Sofosbuvir 400mg Resof 28s DrReddys Sofosbuvir 400mg Sofovir 28s Hetero Sofosbuvir 400mg Sovaldi 28s Mylan Sofosbuvir 400mg Sovihep 28s Zydus Sofosbuvir 400mg Viroclear 28s Abbott Sofosbuvir 400mg Virso 28s Strides Sofosbuvir 400mg Sofosvel 6s Beacon Sofosbuvir 400mg + Velpatasvir 100mg Velpanat 28s Natco Sofosbuvir 400mg + Velpatasvir 100mg Zaltrap 100mg 1s Sanofi Solution A Diluer Pour Perfusion 100mg 4ml Sorafenat 120s Natco Sorafenib 200mg Soranib 30s Cipla Sorafenib 200mg Tadapox 10s Cipla Tadalafil + Dapoxetine Tasigna 200mg 28s Novartis Tasigna 200mg Temoside 250mg 5s Cipla Temozolomide Capsules IP 250mg Ricovir 30s Mylan Tenofovir Disoproxil Fumarate IP 300 mg Tenvir 30s Cipla Tenofovir Disoproxil Fumarate IP 300 mg Teravir 300mg 30s Natco Tenofovir Disoproxil Fumarate IP 300 mg Thalix 100mg 10s x 3 Fresnius Kabi Thalidomide 100mg Xeljanz 5mg 60s Pfizer Tofacitinib Tranemic 500mg 5s x 5 Samarth Life Sciences Pvt Ltd Tranexamic Acid Injection Ip 500mg 5ml 25s Valcyte 60s Roche Valganciclovir 450mg Valgan 450mg 4s Cipla Valganciclovir 450mg Zelboraf 240mg 56s Roche Vemurafenib Sabril 500mg 10s x 10 Aventis Vigabartin 500mg Zoldonat 4mg 1s Natco Zoledronic Acid Zoldria 4mg 1s Cipla Zoledronic Acid 4mg We have distribution from companies such as Biocon, Hetero, Strides, Mylan, Wockhardt and over 60 other companies and we buy products directly from Panacea Biotec, Abbott, Emcure, Micro, Zydus Cadila, Cadila, Biogen, Idec etc.
8 Contact us India Nostrum Impex 59/940, Kuttamparambil Building Thevara Ferry Road, Cochin Kerala , India Ph: LL: MPC Pharma Pvt Ltd Kodambakkam, Chennai, India Ph: contact@mpcpharma.com Peeges Mall of Cochin Corporaton MG Road, Kochi Kerala India Ph: Hira Enterprises Pvt Ltd MCH No & 940 / A to E Tirumala Shah Complex, Basement Ameerpet Hyderabad Ph: No. 25/15, Block 26 East Patel Nagar, New Delhi Ph: New 296 Old 257 Arcot Road, Vadapalani, Chennai , Ph: Our group of Companies Italy Nostrum Impex S.R.L.S. Verona (vr) via Valpantena 2/C cap 37142, VR Ph: Cambodia Haeal Pharma SE Asia CO., LTD #1E1, Street No.02, Phum Sambuor, Sangkat Dangkao, Khan Dangkao, Phnom Penh Cambodia Ph: Singapore Hira Pharma PTE LTD 30 Cecil Street, Prudential Tower Singapore Ph: (India): info@hiraenterprise.com
+91-8071808465 Modern Times Helpline Pharma http://www.moderntimesindia.com/ Modern Times Helpline pharma are exporters, suppliers, dealers & sellers of generic Gefitinib Medicines, Erlotinib Tablets-Sorafenib
Modern Times Helpline Pharma
+91-8079450017 Modern Times Helpline Pharma https://www.indiamart.com/geftinat/ Modern Times Helpline pharmais is Located in Delhi.We are emerging Pharma company. About Us Modern Times Helpline Pharma
Anastrozole. Active Ingredient. Brand Name: Arimidex Strength: 1 mg Dosage Form: Tablets Pack Size: 28 Tabs Company: AstraZeneca
Super Specialty Drugs by Anastrozole Arimidex 1 mg 28 Tabs AstraZeneca Armotraz 1 mg 10 Tabs Cipla Anastrozole Anabrez 1 mg 100 Tabs Sun Decitabine Dacogen 50 mg 1 Vial Eisai Inc. Erlotinib Erlocip-150
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New
+91-8071805536 Medisellers http://www.medisellers.com/ MEDISELLERS is the leading Pharmaceutical Export House in India.We supply best quality products.we are specialist in Anti Cancer Medicines, Steroids
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA
RESISTING THE USUAL. INVESTOR PRESENTATION March, 2015
RESISTING THE USUAL INVESTOR PRESENTATION March, 2015 NATCO S MISSION Quality Medicare at an affordable cost EPS, INR 35 30 25 20 15 10 5 0 34.49 25.02 15.1 16.20 18.20 FY2010 FY 2011 FY 2012 FY 2013 FY
Tadalafil And Dapoxetine Tablet
Tadalafil And Dapoxetine Tablet how to use dapoxetine 30mg dapoxetine hcl in india dapoxetine hydrochloride in india where can i get dapoxetine in india dapoxetine 30 mg and sildenafil 50mg where to buy
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Self Administered Oncology Agents Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Self Administered Oncology Agents Prime Therapeutics will review Prior
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
TODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18
PharmaTrac Overview MAY 18 8434 8956 9655 10422 8112 8917 9549 8258 8921 9406 8668 9630 9381 8662 8373 8999 9013 9796 10413 8742 9315 10050 8458 9180 8601 9092 9767 8364 9145 10583 10173 10387 10217 10476
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
Monographs on ARV and hepatitis medicines in The International Pharmacopoeia
Monographs on ARV and hepatitis medicines in The International Pharmacopoeia Technologies, Standards and Norms 1 The International Pharmacopoeia contains analytical methods and specifications for active
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10
LETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH
1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder
New Global Enterprises
+91-8042973212 New Global Enterprises https://www.medsure.in/ We are a prominent Trader, Exporter and Supplier of highly effective range of Anti Cancer Drugs, Antifungal Medicines and Immunosuppressants
LETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
LETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
LETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
A 10-year summary of kinase small molecule research Text mining AACR abstracts (white paper)
A 10-year summary of kinase small molecule research Text mining AACR abstracts (white paper) Approved Kinase Inhibitors September 2014 Sponsored by PamGene www.pamgene.com The Kinase Activity Profiling
LETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
Generic HCV DAAs. Economics and sustainability. Dr. Andrew Hill Pharmacology and Therapeutics University of Liverpool, UK
Generic HCV DAAs Economics and sustainability Dr. Andrew Hill Pharmacology and Therapeutics University of Liverpool, UK Sunday, 23rd July 2017 Paris, France www.iasociety.org HCV DAAs can be made very
Drug Class Review Monograph GPI Class 12 Antivirals
Drug Class Review Monograph GPI Class 12 Antivirals Review Time Frame: 02/2016 04/2017 Previous Class Review: 05/2016 Background: Antiviral agents are used to treat infections caused by viruses, including,
Opening Address: A Quick Survey Thinking 25 Years Backwards & Forwards
Opening Address: A Quick Survey Thinking 25 Years Backwards & Forwards Jeffrey M. Bockman, PhD Vice President Defined Health 24 th Annual Cancer Progress Conference March 4 th 5 th, 2014 March 4 th 5 th,
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
PRAC recommendations on signals
3 April 2018 1 EMA/PRAC/136563/2018 Pharmacovigilance Risk Assessment Committee (PRAC) Adopted at the 5-8 March 2018 PRAC meeting This document provides an overview of the recommendations adopted by the
Update on the Medicines Patent Pool
Update on the Medicines Patent Pool Sandeep Juneja November 06, 2012 How the Pool works* The Pool is an innovative licensing mechanism for HIV medicines Licensors Patents Feedback Market Impact Product
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
LETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
Laurus Labs Ltd (Laurus) -API leadership & R&D to drive growth
Laurus Labs Ltd (Laurus) -API leadership & R&D to drive growth 1 April 2018 Laurus Labs Ltd (Laurus) 31-03-2018 Recommendation : Buy CMP : Rs 503.00 Target : NA % Allocation : 5% Sector : Pharmaceuticals
1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017
To support national and global efforts to increase access to and the affordability of care and treatment of HIV/AIDS, hepatitis B and C, tuberculosis, malaria, neglected tropical diseases, influenza, diarrhoea
The Medicines Patent Pool: An Update. June 2012 Geneva, Switzerland
The Medicines Patent Pool: An Update June 2012 Geneva, Switzerland The Medicines Patent Pool Royalties Licensor Licensor Patents Generics versions of existing compounds Licensor Licensor Patents Patents
LETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
Recommended comparator products: Medicines for HIV/AIDS and related diseases
Recommended comparator products: Medicines for HIV/AIDS and related diseases Comparator products should be purchased from a well regulated market with stringent regulatory authority 1. Invited medicinal
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
M/s. Hetero Labs Ltd.
:- The 1 st SEC (Gastroenterology&Hepatology) meeting deliberated the proposals on 06.01.2017 and recommended the following:- Agenda New Drugs Division Proposal 1 12-54/16-DC Sofosbuvir and Velpatasvir
Overview of Cancer. Laura Bingell RN Transition Center Nurse for MFP (607)
Overview of Cancer Laura Bingell RN Transition Center Nurse for MFP (607)962-8225 lbingell@ilny.org What is Cancer? A collection of related diseases in which some of the body s cells begin to divide abnormally
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
Update on progress of MPP sublicensees
Update on progress of MPP sublicensees Medicines Patent Pool SEPTEMBER 2018 SUMMARY This presentation showcases the progress made by MPP licensees (generic pharmaceutical companies) To date, MPP has signed
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
Genetics in Cancer Therapy. Raju Kucherlapati, Ph.D. Harvard Medical School
Genetics in Cancer Therapy Raju Kucherlapati, Ph.D. Harvard Medical School RK Financial interests I do not intend to discuss an off-label use of a product during this activity AVEO Pharmaceuticals KEW
John Amis/AP Images for AIDS. Healthcare Foundation
John Amis/AP Images for AIDS Healthcare Foundation Sofosbuvir Bought in 2011 by Gilead for 11 billion: "a huge and risky bet on the next generation of hepatitis C treatments" (Reuters) Patent situation:
NATIVA GROUP. Inspired by Innovation and Technology
NATIVA GROUP Inspired by Innovation and Technology INNOVATION & TECHNOLOGY IS OUR PASSION Nativa is a leading group of pharmaceutical companies in Russia. It develops and produces worldclass complex medicines
MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS
ICON Formulary - November 2016 Class Medicine Name Nappi Strength Form Size Route Manufacturer Abiraterone Acetate ZYTIGA 250 720690001 250 mg 120 ORAL JANSSEN PHARMACEUTICALS Aldesleukin CHIRON IL-2 18
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS
Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases
Medicines for HIV/AIDS and Related Diseases Comparator products should be purchased from a well-regulated market with a stringent regulatory authority. 1 Invited medicinal products Abacavir, 60 mg, 300
Global Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml
: I approve the minutes of 32 nd SEC (Antimicrobial, Antiviral, Antiparasitic and Antifungal) held on 11.04.2017 at CDSCO HQ New Delhi and recommended the following: Agend New Drugs Division 1 12-34/12-DC
LETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS
Name of firm/applicant
Recommendation:- The 18 th Subject Expert Committee (Oncology & Hematology) deliberated the proposals on 04.07.2014 and recommended the following:- Agenda no. Drug name Name of firm/applicant Recommendations
HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse
HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs),
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
LETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,
What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations
Review of predictive biomarkers in European Medicines Agency (EMA) drugs
Review of predictive biomarkers in European Medicines Agency (EMA) drugs Kinga Malottki, Mousumi Biswas, Jon Deeks, Richard Riley, Charles Craddock, Lucinda Billingham 10 February 2012 Objectives What
VMG Pharmaceuticals Pvt. Ltd.
S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets
Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy
Last Updated 22-Feb-18 Date of last update Protocol Number Tumour Group Protocol Name on NCCP website 22/02/2018 221 Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy 249 Gynaecology Intrathecal
Hepatitis C Virus Management
Hepatitis C Virus Management FDA-Approved Medications Hepatitis C is caused by a virus and results in liver inflammation, which can lead to advanced liver disease and/or liver cancer. An estimated 3 to
File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY
Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249
Last updated Feb 9, 2018 Revision due Protocol Name on NCCP website Tumour Group Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Two Day Etoposide CISplatin
CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
Targeted Cancer Therapies
Targeted Cancer Therapies Primary Care Training Programme 14 th February 2018 Sin Chong Lau Consultant in Medical Oncology Financial Disclosure Honoraria: Amgen, Pfizer, Roche, Sanofi, Servier Meetings:
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709
Information for Vermont Prescribers of Prescription Drugs Long Form
Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale
New Delhi, the 18 th December, 2017 ORDER
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
WHO Global Price Reporting Mechanism the importance of data registration for the regulation of antiretrovirals (ARV) and access to treatment
WHO Global Price Reporting Mechanism the importance of data registration for the regulation of antiretrovirals (ARV) and access to treatment Boniface Dongmo Nguimfack HIV/Technology and Commodities 1 AMDS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS. HLC174A October Usha Nagavarapu Project Analyst
GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS HLC174A October 2015 Usha Nagavarapu Project Analyst ISBN: 1-62296-167-6 BCC Research 49 Walnut Park, Building 2 Wellesley,
PRAC recommendations on signals
15 September 2016 EMA/PRAC/551805/2016 Corr 1 Pharmacovigilance Risk Assessment Committee (PRAC) Adopted at the PRAC meeting of 30 August-2 September 2016 This document provides an overview of the recommendations
+91-9643336811 Deep Lifecare www.deeplifecare.in We are engaged in manufacturing, trading, exporting and supplying wide range of Pain killer Tablets, Anti Cancer Medicine and Weight Loss Tablet. The medicine
Pharmacy Medical Necessity Guidelines: Hepatitis C Virus
Pharmacy Medical Necessity Guidelines: Hepatitis C Virus Effective: January 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX)
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Self Administered Oncology Agents Page 1 of 18 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Self Administered Oncology Agents Prime Therapeutics will review Prior
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
The hepatitis C treatment revolution: how to avoid Asia missing out
Journal of Virus Eradication 2015; 1: Q1 The hepatitis C treatment revolution: how to avoid Asia missing out Nick Walsh 1 *, Nicolas Durier 2, Giten Khwairakpam 2, Annette H Sohn 2, Ying-Ru Lo 1 1 HIV,
DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days
Last updated Oct 17, 2018 Tumour Group Protocol Number Protocol Name on NCCP website Breast 200 Trastuzumab (IV) Monotherapy 21 days 201 Trastuzumab (IV) Monotherapy 7 days 202 DOCEtaxel Monotherapy 100mg/m2
Safe Practices in Oral Anticancer Medications: Implications for Community Pharmacy
Safe Practices in Oral Anticancer Medications: Implications for Community Pharmacy Faculty Disclosures Dr. Holle has provided content expertise on patient education materials for Innocrin Pharmaceuticals
NICE-approved drugs for specialities which fall outside of the services currently provided by the Trust
NICE-approved drugs for specialities which fall outside of the services currently provided by the Trust Drug NICE-approved use NICE TA link Abiraterone Abiraterone Adalimumab Adalimumab Adalimumab Adefovir
List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)
Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version
Oncology Pipeline Analytics
Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015-2022 COPD and
NICE TECHNOLOGY APPRAISAL MEDICINES REPORT 2017
NICE TECHNOLOGY PPRISL MEDICINES REPORT St George s Healthcare NHS Trust key for medicine-related NICE Technology ppraisals. has been approved by the Drugs and Therapeutics Committee as recommended within
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on 05.11.2014 and recommended the following:- Agend a No. File No. 1. File No.: 12-75/13-DC Afatinib film coated tablet
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars
PBS Growth The changing composition of the PBS PBS Top 10 drugs in transition Shifting sands for industry as generic volume soars The under co-payment market PBS Update 2014-15 Growth in PBS spending was
The Global Health Impact Index
The Global Health Impact Index Ranking Explanation Reference Table Drug Abbreviation Drug Name 1. AL 1. Artemether-Lumefantrine 2. AS+AQ 2. Artesunate + Amodiaquine 3. AS+MQ 3. Artesunate + Mefloquine
Organ Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205